麦克森加拿大的争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 9 条
2022
2021
前员工起诉McKesson，指控种族歧视
提起诉讼
McKesson一名前员工提起诉讼，指控公司对其实施种族歧视。他称，非裔员工因使用样品账户而被解雇，而同样使用该账户的非非裔团队成员没有被解雇。相关内容为诉讼中的指控。
来源摘录
Team members who were not African-American but who had also used the sample account for personal purposes were not terminated, according to the lawsuit.
A former employee of McKesson Medical-Surgical Inc. filed a lawsuit in an Eastern Virginia court last week for alleged racial discrimination by the medical supply company.
2021
纽约州与药品分销商达成11亿美元阿片类药物和解
和解
纽约州与 Cardinal Health、McKesson 和 AmerisourceBergen 达成11亿美元和解，涉及指称这些公司助长阿片类药物危机的诉讼。协议要求分销商建立阿片类药物出货信息清算系统，以帮助标记可疑订单。
来源摘录
The agreement also requires the distributors to create a clearinghouse of their opioid shipments to help flag suspicious orders.
New York has agreed to a $1.1 billion settlement with three of the nation’s largest drug distributors — Cardinal Health, McKesson and Amerisource Bergen — over claims they helped fuel the opioid epidemic.
2020
2020
俄克拉何马州起诉阿片类药物分销商
提起诉讼
俄克拉何马州总检察长Mike Hunter提起诉讼，将Cardinal Health、McKesson和AmerisourceBergen列为被告。诉讼指称这些公司向俄克拉何马州分销了过量阿片类药物。报道称这些公司的责任仅为指称，并未认定成立。该事件记录为州总检察长针对这三家分销商提起的法律诉讼，核心是指称俄克拉何马州存在阿片类药物过量供应。
俄克拉何马州总检察长Mike Hunter起诉Cardinal Health、McKesson和AmerisourceBergen，指称这些公司向俄克拉何马州分销了过量阿片类药物。报道并未认定这些公司的责任成立。
当事方说明的目的. 诉讼旨在追究被告因涉嫌助长密歇根州非法阿片类药物市场而造成破坏的民事责任。
品牌回应
否认 — McKesson
McKesson said in a statement Monday that “any suggestion that (the company) drove demand for opioids in this country reflects a fundamental misunderstanding and mischaracterization of our role as a distributor.”
来源摘录
Oklahoma Attorney General Mike Hunter on Monday brought a lawsuit against three distributors of opioids
Hunter filed the lawsuit in Cleveland County District Court against Cardinal Health Inc., McKesson Corp. and AmerisourceBergen Corp.
The lawsuit said the defendants “distributed what can only be called a major oversupply of opioids into Oklahoma.”
2017
2012
1999
1938